查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585763

骨生长刺激剂市场：按产品、应用和分销管道 - 2025-2030 年全球预测

Bone Growth Stimulators Market by Product, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

骨生长刺激剂市场2023年估值为25亿美元，预计2024年将达到26.8亿美元，复合年增长率为7.54%，预计到2030年将达到41.6亿美元。

骨骼生长刺激器是用于加速骨折和脊椎融合手术癒合过程的医疗设备。它在促进骨形成方面发挥着重要作用，骨形成可能导致癒合延迟或受损。它主要用于整形外科、外科和牙科，以治疗骨不连、脊椎融合和其他骨相关疾病。它的主要用途也扩展到需要骨再生的治疗方法，这使得它对于创伤和损伤的恢復至关重要。最近的进展已将这些设备的最终使用范围扩大到医院、门诊手术中心和整形外科专科诊所。

主要市场统计
基准年[2023] 25亿美元
预测年份 [2024] 26.8亿美元
预测年份 [2030] 41.6亿美元
复合年增长率（%） 7.54%

骨生长刺激剂市场受到骨相关疾病日益流行、对非侵入性治疗的需求不断增加以及全球老龄化人口增加（更容易患退化性骨疾病）的显着推动。超音波和脉衝电磁场技术等技术进步将进一步支持市场扩张。医疗保健支出的增加和意识的提高是进一步推动因素。然而，市场面临着高成本和严格的法律规范阻碍设备核准和后续商业化的挑战。

新的商机在于个人化骨骼生长刺激器的开发以及物联网的集成，以提高患者的依从性和治疗效果。这可能会带来復健医学领域更多的创新应用，以及合併和合作以实现技术进步的可能性。对于公司而言，投资研发以开发具有成本效益的可携式设备有可能开拓服务不足的区域市场并扩大消费群。然而，来自传统疼痛管理解决方案的竞争以及对这些设备有效性的怀疑仍然是障碍。

关注治疗精确度和微创性，以及游说有利的医疗政策，对于维持市场成长至关重要。开拓未开发的市场并利用巨量资料分析来预测和改善患者的治疗结果是一条充满希望​​的创新之路。当我们转向以证据为基础、以患者为中心的方法时，了解这个市场的动态本质至关重要。

市场动态：揭示快速发展的骨生长刺激剂市场的关键市场洞察

供需的动态交互作用正在改变骨骼生长刺激剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 老年人口增加以及慢性病和关节炎的发生率增加
    • 骨折和事故增加
    • 越来越多的患者对微创和非侵入性手术治疗的偏好
  • 市场限制因素
    • 电池寿命有限且有可能发生短路
  • 市场机会
    • 富含血小板的血浆和骨形成蛋白的出现
    • 具有成本效益的骨骼生长刺激剂的可用性
  • 市场挑战
    • 感染的可能性以及需要进行翻修手术以移除植入的装置

波特五力：引领骨生长刺激剂市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解骨生长刺激剂市场的外部影响

外部宏观环境因素在塑造骨骼生长刺激剂市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解骨骼生长刺激剂市场的竞争格局

对骨生长刺激器市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵骨生长刺激器市场供应商的绩效评估

FPNV 定位矩阵是评估骨骼生长刺激器市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了骨生长刺激剂市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对骨生长刺激剂市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口增加以及慢性病和关节炎的发生率增加
      • 骨折和事故发生率增加
      • 患者对微创和非侵入性手术治疗的偏好正在增加
    • 抑制因素
      • 电池寿命有限且有可能发生短路
    • 机会
      • 富含血小板的血浆和骨形成蛋白的出现
      • 具有成本效益的骨骼生长刺激剂的可用性
    • 任务
      • 感染的可能性，需要第二次手术取出植入的装置
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章骨生长刺激剂市场：副产品

  • 骨骼生长刺激剂
  • 骨形成蛋白
  • 富含血小板的血浆

第七章骨生长刺激器市场：依应用

  • 骨折延迟癒合和不癒合骨折
  • 口腔颚颜面外科
  • 脊椎融合手术

第八章骨生长刺激剂市场：按分销管道

  • 学术研究所
  • 合约调查机构
  • 居家护理
  • 医院/诊所

第九章美洲骨生长刺激器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区骨骼生长刺激剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的骨骼生长刺激器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Altis Biologics（Pty.）Ltd.
  • Arthrex, Inc.
  • Bioventus LLC
  • Boston Scientific Corporation
  • BTT Health GmbH
  • DJO, LLC
  • Elizur Corporation
  • Ember Therapeutics, Inc.
  • EMS Physio Ltd.
  • Ito Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Kinex Medical Company, LLC
  • Medtronic PLC
  • Orthofix Medical Inc.
  • Ossatec Benelux Ltd.
  • Regen Lab SA
  • RS Medical
  • Stimulate Health Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
  • ZimVie Inc.
Product Code: MRR-02026C4CB3B9

The Bone Growth Stimulators Market was valued at USD 2.50 billion in 2023, expected to reach USD 2.68 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 4.16 billion by 2030.

Bone growth stimulators are medical devices used to enhance the healing process of fractures or spinal fusions. They are key in promoting osteogenesis where healing might otherwise be slow or impaired. They are primarily used in orthopedic, surgical, and dental settings to treat non-union fractures, spinal fusions, and other bone-related conditions. Key applications extend to therapeutic procedures that require bone regeneration, making them imperative in trauma and injury recovery. Recent advancements have expanded the end-use scope of these devices to include hospitals, ambulatory surgical centers, and specialized orthopedic clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 2.50 billion
Estimated Year [2024] USD 2.68 billion
Forecast Year [2030] USD 4.16 billion
CAGR (%) 7.54%

The bone growth stimulators market is significantly driven by the increasing incidence of bone-related disorders, augmented demand for non-invasive therapies, and a rise in the global aging population susceptible to degenerative bone diseases. Technological advancements, such as ultrasound and pulsed electromagnetic field technologies, further bolster market expansion. Increasing healthcare expenditure and heightened awareness contribute further momentum. However, the market faces challenges with high costs and the stringent regulatory framework hampering device approval and subsequent commercialization.

Emerging opportunities lie in developing personalized bone growth stimulators and integrating IoT to enhance patient compliance and therapy outcomes. This could lead to more innovative applications in rehabilitation medicine and potential mergers and collaborations for technological advancements. For businesses, investing in R&D to create cost-effective, portable devices could tap into underserved regional markets and expand consumer base. Nonetheless, competition from traditional pain management solutions and skepticism related to the efficacy of these devices pose ongoing roadblocks.

To sustain market growth, focusing on the precision and minimal invasiveness of treatments, while lobbying for favorable healthcare policies, will be crucial. Exploring underdeveloped markets and leveraging big data analytics to predict and improve patient outcomes represent promising avenues for innovation. Understanding this market's dynamic nature is essential as it transitions increasingly toward an evidence-based, patient-centered approach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Growth Stimulators Market

The Bone Growth Stimulators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in geriatric population and incidence of chronic diseases and arthritis
    • Increase in occurrences of fracture and accidents
    • Growing patient inclination toward minimally invasive & non-invasive surgical treatments
  • Market Restraints
    • Limited battery life and potential short circuiting
  • Market Opportunities
    • Emergence of platelet-rich plasma and bone morphogenetic protein
    • Availability of cost effective bone growth stimulation devices
  • Market Challenges
    • Potential for infection and need for a second procedure for removal of the implanted devices

Porter's Five Forces: A Strategic Tool for Navigating the Bone Growth Stimulators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Growth Stimulators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Growth Stimulators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Growth Stimulators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Growth Stimulators Market

A detailed market share analysis in the Bone Growth Stimulators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Growth Stimulators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Growth Stimulators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Growth Stimulators Market

A strategic analysis of the Bone Growth Stimulators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Growth Stimulators Market, highlighting leading vendors and their innovative profiles. These include Altis Biologics (Pty.) Ltd., Arthrex, Inc., Bioventus LLC, Boston Scientific Corporation, BTT Health GmbH, DJO, LLC, Elizur Corporation, Ember Therapeutics, Inc., EMS Physio Ltd., Ito Co., Ltd., Johnson & Johnson Services, Inc., Kinex Medical Company, LLC, Medtronic PLC, Orthofix Medical Inc., Ossatec Benelux Ltd., Regen Lab SA, RS Medical, Stimulate Health Inc., Stryker Corporation, Terumo Corporation, Zimmer Biomet Holdings, Inc., and ZimVie Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Growth Stimulators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet-Rich Plasma.
  • Based on Application, market is studied across Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Spinal Fusion Surgeries.
  • Based on Distribution Channel, market is studied across Academic & Research Institutes, Contract Research Organizations, Home Care, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in geriatric population and incidence of chronic diseases and arthritis
      • 5.1.1.2. Increase in occurrences of fracture and accidents
      • 5.1.1.3. Growing patient inclination toward minimally invasive & non-invasive surgical treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Limited battery life and potential short circuiting
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of platelet-rich plasma and bone morphogenetic protein
      • 5.1.3.2. Availability of cost effective bone growth stimulation devices
    • 5.1.4. Challenges
      • 5.1.4.1. Potential for infection and need for a second procedure for removal of the implanted devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Growth Stimulators Market, by Product

  • 6.1. Introduction
  • 6.2. Bone Growth Stimulation Devices
  • 6.3. Bone Morphogenetic Proteins
  • 6.4. Platelet-Rich Plasma

7. Bone Growth Stimulators Market, by Application

  • 7.1. Introduction
  • 7.2. Delayed Union & Nonunion Bone Fractures
  • 7.3. Oral & Maxillofacial Surgeries
  • 7.4. Spinal Fusion Surgeries

8. Bone Growth Stimulators Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Home Care
  • 8.5. Hospitals & Clinics

9. Americas Bone Growth Stimulators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bone Growth Stimulators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bone Growth Stimulators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Altis Biologics (Pty.) Ltd.
  • 2. Arthrex, Inc.
  • 3. Bioventus LLC
  • 4. Boston Scientific Corporation
  • 5. BTT Health GmbH
  • 6. DJO, LLC
  • 7. Elizur Corporation
  • 8. Ember Therapeutics, Inc.
  • 9. EMS Physio Ltd.
  • 10. Ito Co., Ltd.
  • 11. Johnson & Johnson Services, Inc.
  • 12. Kinex Medical Company, LLC
  • 13. Medtronic PLC
  • 14. Orthofix Medical Inc.
  • 15. Ossatec Benelux Ltd.
  • 16. Regen Lab SA
  • 17. RS Medical
  • 18. Stimulate Health Inc.
  • 19. Stryker Corporation
  • 20. Terumo Corporation
  • 21. Zimmer Biomet Holdings, Inc.
  • 22. ZimVie Inc.

LIST OF FIGURES

  • FIGURE 1. BONE GROWTH STIMULATORS MARKET RESEARCH PROCESS
  • FIGURE 2. BONE GROWTH STIMULATORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BONE GROWTH STIMULATORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BONE GROWTH STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE GROWTH STIMULATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE GROWTH STIMULATORS MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY BONE GROWTH STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DELAYED UNION & NONUNION BONE FRACTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY ORAL & MAXILLOFACIAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY SPINAL FUSION SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 147. BONE GROWTH STIMULATORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. BONE GROWTH STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2023